S2095 HCPCS code: Transcatheter occlusion or embolization for tumor destruction, percutaneous, any method, using yttrium-90 microspheres

S2095 is the HCPCS Level II code for transcatheter occlusion or embolization for tumor destruction, percutaneous, any method, using yttrium-90 microspheres. Its Medicare coverage code is I (Not payable by Medicare): Medicare does not pay separately under this code; another code applies.

Code details

FieldValue
SectionS codes — Temporary national codes (non-Medicare)
Coverage codeI — Not payable by Medicare
Pricing indicator00 — Not separately priced by Medicare
BETOS categoryZ2
Added2004-01-01
Last action effective2004-01-01

What changed for S2095

Frequently asked questions

What is HCPCS code S2095?

S2095 is the HCPCS Level II code for transcatheter occlusion or embolization for tumor destruction, percutaneous, any method, using yttrium-90 microspheres. Short descriptor: "Transcath emboliz microspher".

Does Medicare cover S2095?

Coverage code I — Not payable by Medicare. Medicare does not pay separately under this code; another code applies.

Related S20 codes

Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.

Next steps

Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.

All S codes · HCPCS lookup